Bavarian Nordic A/S (BAVA.CO) stock: key figures, P/E, revenue and dividend
Health Care · Denmark · ISIN DK0015998017
Bavarian Nordic A/S financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 5.72 bn DKK | 6.17 bn DKK |
| Gross profit | 2.82 bn DKK | 2.92 bn DKK |
| Operating income | 1.06 bn DKK | 1.03 bn DKK |
| EBIT | 985.00 m DKK | 920.00 m DKK |
| Net income | 987.00 m DKK | 1.38 bn DKK |
| Diluted EPS – continuing operations | 12.57 DKK | 17.57 DKK |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Bavarian Nordic A/S
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV, that is in phase 2 trial for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, England, Finland, Switzerland, Japan, Austria, Italy, Spain, Taiwan, Saudi Arabia, Australia, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
More stocks
- Chongqing Brewery Co Ltd (600132.SS)
- All Ring Tech Co Ltd (6187.TWO)
- Privia Health Group, Inc. (PRVA)
- Sino-American Silicon Products (5483.TWO)
- Vusion SA (VU.PA)
- JPMorgan American Investment Trust PLC (JAM.L)
- Beam Therapeutics Inc. (BEAM)
- IMAX CORP (IMAX)
- Firefly Aerospace Inc. (FLY)
- Hanjin Kal (18064K.KS)
- Valiant Holding AG (VATN.SW)
- China National Building Material Co Ltd (3323.HK)
Not investment advice. All data without warranty, price as of 04.11.2026. Details in the risk notice.